Pivotal phase III trial of lubipristone in US patients with chronic idiopathic constipation
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2011
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation
- Focus Registrational; Therapeutic Use
- 05 Aug 2011 Sucampo Pharmaceuticals has filed a Marketing Authorization Application (MAA) to the UK Medicines and Healthcare Products Regulatory Agency (MHRA), based on the results of the two pivotal trial in the USA and Japan.
- 05 Nov 2010 New trial record.